Osteoporosis Flashcards
(40 cards)
Builds new bone
Osteoblasts
Reabsorbs bone
Osteoclasts
Medications that increase the risk of Osteoporosis
PPIs
Heparin
Anticonvulsants
Glucocorticoids
Lithium
Aluminum
SSRIs
What T-Score indicates Osteopenia
-1 to -2.5
What T-Score indicates Osteoporosis
Less than -2.5
Universal Recommendations for Osteoporosis Prevention
Adequate Calcium and Vitamin D
Exercise
Avoid Smoking
Avoid Alcohol
Drugs for Osteoporosis
Bisphosphonates
- Alendronate
- Risedronate
- Ibandronate
- Zoledronic Acid
Raloxifene
Calcitonin
Teriparatide
HRT
Conjugated Estrogens + Bazedoxifene
Denosumab
Binds to hydroxyapatite in bone and inhibits osteoclasts
Alendronate (Fosamax)
- weekly oral
- half life in bone exceeds 10 years
What can decrease the oral bioavailability of Alendronate by up to 60%
Coffee + Orange Juice
How should you take Bisphosphonates?
Morning
Empty Stomach
6-8 oz of Water and Remain Seated Upright for 30 - 60 mins
Which Bisphosphonates should be taken at least 30-60 minutes before eating or taking any other medications?
Risedronate
Adverse Drug Reactions of Bisphosphonates
↓ Calcium
Acid Reflux
Dyspepsia + Gastritis
Esophageal + Gastric Ulcers
Warnings and Precautions of Bisphosphonates
Atypical Femur Fracture
Osteonecrosis of the Jaw
What medication class should you not take with Bisphosphonates?
Antacids
Contraindications of Bisphosphonates
Esophageal Abnormalities
Inability to sit upright for 30 minutes
CrCl < 30 mL/min
Bisphosphonate that does NOT have approval for treatment of glucocorticoid induced osteoporosis
Ibandronate
Bisphosphonate that has a delayed release dosage form that is taken immediately BEFORE breakfast
Risedronate
Bisphosphonate that is given as a once year infusion.
Infusion related flu-like symptoms can occur after the first dose.
Administration of NSAIDs may help with symptoms
Zoledronic Acid
Selective estrogen receptor modulator
(SERM)
Decreases bone resorption.
CANNOT RESTORE BONE.
Reduces risk of vertebral fractures.
NO evidence of reduced non-vertebral fractures.
Raloxifene (Evista)
Clinical Use of Raloxifene (Evista)
Prevention + Treatment of Osteoporosis in Postmenopausal Women
Less effective in preventing bone loss vs. bisphosphonate
Contraindications of Raloxifene (Evista)
DVT
Pulmonary Embolism
Stroke
Retinal Vein Thrombosis
Adverse Drug Reactions of Raloxifene
Hot Flashes
Flu-Like Symptoms
Depression
Pregnancy Category X
Human Monoclonal Antibody to RANKL
Involved in mediation of Osteoclast Activity.
Reduces the risk of Vertebral + Non-Vertebral fractures
Denosumab (Prolia)
- SQ every 6 months
Who is Denosumab (Prolia) approved for?
Men + Postmenopausal Women
Reserved for those who are intolerant or unresponsive to Bisphosphonates